Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Piramal Pharma Solutions to Collaborate with Epirium Bio on Exclusive Integrated Development & Manufacturing Program for Orphan Drugs
Friday, August 28, 2020Piramal Pharma Solutions a leading contract development and manufacturing organization CDMO announced that the company will be partnering with Epirium Bio on an exclusive manufacturing relationship for new orphan drugs targeting rare diseases with hi...
BeiGene Announces Exclusive License Agreement for Neutralizing COVID-19 Antibodies Developed by Singlomics Biopharmaceuticals
Friday, August 28, 2020BeiGene Ltd and Singlomics Biopharmaceuticals Co Ltd announced that the companies have executed an exclusive license agreement for BeiGene to develop manufacture and commercialize globally outside of greater China Singlomics investigational antiCOVID...
Ivy Brain Tumor Center and Vivace Therapeutics Collaborate to Test Targeted Agent in Glioblastoma and Meningioma
Thursday, August 27, 2020Ivy Brain Tumor Center at Barrow Neurological Institute announced a new collaboration with Vivace Therapeutics The Ivy Brain Tumor Center which employs a bold earlyphase clinical trials strategy will evaluate Vivaces novel development compound VT as...
MedGenome announces Strategic Collaboration in Parkinson's Disease with Denali Therapeutics
Thursday, August 27, 2020MedGenome a leading genomic diagnostics research and data company based in Foster City CA and Bangalore India announced that it has formed a strategic discovery collaboration focused on novel discoveries in Parkinsons Disease PD with Denali Therapeut...
EpiVax Announces Licensing of a COVID-19 Vaccine Candidate to EpiVax Therapeutics
Wednesday, August 26, 2020EpiVax Inc a Rhode Island based company known as a leader in the computational vaccination industry announced that it has acquired a Licensed a vaccine candidate against COVID under the identifier EPVCoV to EpiVax Therapeutics EVT a New York based co...
Engitix Signs Collaboration and Licensing Agreement with Takeda to Develop Anti-Fibrotic Therapies in Advanced Liver Diseases
Wednesday, August 26, 2020Engitix Ltd Engitix a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix ECM platform entered into a licensing and collaboration agreement with Takeda Pharmaceutic...
HitGen and Almirall Announce Achievement of Milestone in Their Strategic Collaboration
Wednesday, August 26, 2020HitGen Inc announced that the company has achieved a milestone in their strategic collaboration with Almirall to develop a novel class of drugs The licensed compounds were identified using HitGens leading technology platform which involved screening...
Harbour BioMed Signs Strategic Collaboration Agreement with Vir Biotechnology to Develop Novel Therapies for Immuno-Oncology and Infectious Diseases
Tuesday, August 25, 2020Harbour BioMed HBM a global clinicalstage biopharmaceutical company announced that it has entered into a strategic collaboration with Vir Biotechnology Nasdaq VIR a clinicalstage immunology company to discover develop and commercialize potential nove...
Bio-Thera Solutions and BeiGene Announce License, Distribution, and Supply Agreement for Avastin® (Bevacizumab) Biosimilar BAT1706 in China
Tuesday, August 25, 2020BioThera Solutions Ltd a commercial stage biopharmaceutical company SH and BeiGene Ltd announced that the companies have executed a license distribution and supply agreement for China for BioTheras BAT an investigational biosimilar to Avastin bevaciz...
AbbVie, Harvard University Form Research Alliance to Address Emergent Viral Diseases
Tuesday, August 25, 2020AbbVie and Harvard University today announced a million collaborative research alliance launching a multipronged effort at Harvard Medical School HMS to study and develop novel therapies against emergent viral infections with a focus on those caused...
